Matthew Meyer

Matthew Meyer

Auto-generated profile, based on publicly available information

Matthew Meyer

La Jolla Institute for Immunology, La Jolla, CA 1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AMAlex Marki
Alex Marki
KBKonrad Buscher
Konrad Buscher
CLCristina Lorenzini
Cristina Lorenzini
MMMatthew Meyer
Matthew Meyer
Ryosuke SaigusaRyosuke Saigusa
Ryosuke Saigusa
Klaus LeyKlaus Ley
Klaus Ley
Rolling neutrophils form tethers with submicron diameters. Here, we report that these tethers detach, forming elongated neutrophil-derived structures (ENDS) in the vessel lumen. We studied ENDS formation in mice and humans in vitro and in vivo. ENDS do not contain mitochondria, endoplasmic reticulum, or DNA, but are enriched for S100A8, S100A9, and 57 other proteins. Within hours of formation, ENDS round up, and some of them begin to present phosphatidylserine on their surface (detected by annexin-5 binding) and release S100A8–S100A9 complex, a damage-associated molecular pattern protein that is a known biomarker of neutrophilic inflammation. ENDS appear in blood plasma of mice upon induction of septic shock. Compared with healthy donors, ENDS are 10–100-fold elevated in blood plasma of septic patients. Unlike neutrophil-derived extracellular vesicles, most ENDS are negative for the tetraspanins CD9, CD63, and CD81. We conclude that ENDS are a new class of bloodborne submicron particles with a formation mechanism linked to neutrophil rolling on the vessel wall.